BioCorRx Inc. (OTCMKTS:BICX) Files An 8-K Other Events

BioCorRx Inc. (OTCMKTS:BICX) Files An 8-K Other Events
Item 8.01 Other Items.

Story continues below

On January 18, 2019, BioCorRx Inc., a Nevada corporation (the “Company”) received notice from Financial Industry Regulatory Authority (“FINRA”) that the 1-for-100 reverse stock split of the Company’s common stock (the “Reverse Split”) had been approved and would take effect at the opening of trading on January 22, 2019.

Effective January 22, 2019, as a result of the Reverse Split, every 100 shares of the Company’s issued and outstanding common stock will be converted into one share of issued and outstanding common stock. The number of authorized shares remains unchanged. No fractional shares will be issued in connection with the Reverse Split. Any fractional shares of common stock resulting from the Reverse Split will be rounded up to the nearest whole share. It is not necessary for stockholders to exchange their existing stock certificates for new stock certificates in connection with the Reverse Split. Stockholders who hold their shares in brokerage accounts are not required to take any action to exchange their shares.

The Company’s shares will continue to trade on The OTC Markets marketplace under the symbol “BICX” with the letter “D” added to the end of the trading symbol for a period of 20 trading days (ending on February 19, 2019) to indicate that the Reverse Split has occurred.

The Reverse Split has no impact on shareholders’ proportionate equity interests or voting rights in the Company or the par value of the Company’s common stock, which remains unchanged.

On January 23, 2019, the Company issued a press release with regard to the Reverse Split. The press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.





Press Release dated January 23, 2019

BioCorRx Inc. Exhibit
EX-99.1 2 bicx_ex991.htm PRESS RELEASE bicx_ex991.htmEXHIBIT 99.1       BioCorRx Announces Reverse Stock Split in Preparation for Proposed Uplisting to NASDAQ Capital Market   ANAHEIM,…
To view the full exhibit click here

About BioCorRx Inc. (OTCMKTS:BICX)

BioCorRx, Inc., formerly Fresh Start Private Management, Inc., is a holding company. The Company is an addiction healthcare solutions company operating in Santa Ana, California. The Company, through its subsidiary, Fresh Start Private, Inc., provides alcoholism and opioid treatment program. It offers a medication-assisted treatment program that combines non-addictive medication coupled with psycho-social counseling. It also distributes and licenses the BioCorRx Recovery Program for alcoholism and opioid addiction treatment. The BioCorRxO Recovery Program consists of over two parts, which include an implant, administered by a licensed physician, of a compounded formulation of the drug, Naltrexone (implanted under the skin) (the Implant), which reduces alcohol cravings over a period of time, and a structured, intensive one on one counseling program developed by it. It offers BioCorRx Recovery Program in over 10 locations, including California, Arizona, Atlanta, Illinois and others.

An ad to help with our costs